Milan Frélich

Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction

Jaroslav Meluzín, Lenka Špinarová, Jan Černý et al. · Journal of the American College of Cardiology · 1998 · 245 citations

Percutaneous Coronary Intervention, Heart Failure, Cardiovascular Disease +11

Prognostic value of the amount of dysfunctional but viablemyocardium in revascularized patients with coronary arterydisease and left ventricular dysfunction. Investigators of thismulticenter study

Jaroslav Meluzı́n, Jan Černý, Milan Frélich et al. · 1998 · 71 citations

Percutaneous Coronary Intervention, Heart Failure, Cardiovascular Disease +12

Dobutamine echocardiography in predicting improvement in global left ventricular systolic function after coronary bypass or angioplasty in patients with healed myocardial infarcts

Jaroslav Meluzı́n, Carlos G. Cigarroa, M. Elizabeth Brickner et al. · The American Journal of Cardiology · 1995 · 63 citations

Heart Failure, Cardiovascular Disease, Coronary Bypass +11

Prognosis of Patients with Chronic Coronary Artery Disease and Severe Left Ventricular Dysfunction. The Importance of Myocardial Viability

Jaroslav Meluzı́n, Jan Černý, Lenka Špinarová et al. · European Journal of Heart Failure · 2003 · 31 citations

Single Effects of Apolipoprotein B, (a), and E Polymorphisms and Interaction between Plasminogen Activator Inhibitor-1 and Apolipoprotein(a) Genotypes and the Risk of Coronary Artery Disease in Czech Male Caucasians

Petr Beneš, Jaroslav Benedı́k, Milan Frélich et al. · Molecular Genetics and Metabolism · 2000 · 23 citations

Cardiovascular Epidemiology, Cardiovascular Disease, Czech Male Caucasians +8